BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37293004)

  • 1. Development of Cas13a-based Assays for
    Allan-Blitz LT; Shah P; Adams G; Branda JA; Klausner JD; Goldstein R; Sabeti PC; Lemieux JE
    medRxiv; 2023 May; ():. PubMed ID: 37293004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Cas13a-based assays for
    Allan-Blitz L-T; Shah P; Adams G; Branda JA; Klausner JD; Goldstein R; Sabeti PC; Lemieux JE
    mSphere; 2023 Oct; 8(5):e0041623. PubMed ID: 37732792
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification.
    Luo H; Chen W; Mai Z; Yang J; Lin X; Zeng L; Pan Y; Xie Q; Xu Q; Li X; Liao Y; Feng Z; Ou J; Qin X; Zheng H
    J Antimicrob Chemother; 2022 Feb; 77(3):656-664. PubMed ID: 34894246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Performance of Cas13a-based Point-of-Care Lateral Flow Assay for Detecting
    Allan-Blitz LT; Sanders G; Shah P; Adams G; Jarolimova J; Ard K; Branda JA; Klausner JD; Sabeti PC; Lemieux JE
    medRxiv; 2024 Mar; ():. PubMed ID: 38496586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
    Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D;
    J Antimicrob Chemother; 2019 Jul; 74(7):1820-1824. PubMed ID: 30897201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.
    Pond MJ; Hall CL; Miari VF; Cole M; Laing KG; Jagatia H; Harding-Esch E; Monahan IM; Planche T; Hinds J; Ison CA; Chisholm S; Butcher PD; Sadiq ST
    J Antimicrob Chemother; 2016 Apr; 71(4):897-902. PubMed ID: 26817487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility.
    Buckley C; Trembizki E; Donovan B; Chen M; Freeman K; Guy R; Kundu R; Lahra MM; Regan DG; Smith H; Whiley DM;
    J Antimicrob Chemother; 2016 Feb; 71(2):353-6. PubMed ID: 26538505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.
    Knapp JS; Mesola VP; Neal SW; Wi TE; Tuazon C; Manalastas R; Perine PL; Whittington WL
    Sex Transm Dis; 1997 Jan; 24(1):2-7. PubMed ID: 9018776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
    Ayfan AKS; Macdonald J; Irwin AD; Zowawi HM; Forde BM; Paterson DL; Lahra MM; Whiley DM
    J Antimicrob Chemother; 2022 Oct; 77(11):2933-2936. PubMed ID: 35880750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
    Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
    J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa.
    Maduna LD; Kock MM; van der Veer BMJW; Radebe O; McIntyre J; van Alphen LB; Peters RPH
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868325
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004.
    Donegan EA; Wirawan DN; Muliawan P; Schachter J; Moncada J; Parekh M; Knapp JS
    Sex Transm Dis; 2006 Oct; 33(10):625-9. PubMed ID: 16601661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loop-Mediated Isothermal Amplification Assay for Identifying Neisseria gonorrhoeae Nonmosaic
    Shimuta K; Takahashi H; Akeda Y; Nakayama SI; Ohnishi M
    Microbiol Spectr; 2022 Oct; 10(5):e0233522. PubMed ID: 36000906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
    Dillon JA; Li H; Sealy J; Ruben M; Prabhakar P;
    Sex Transm Dis; 2001 Sep; 28(9):508-14. PubMed ID: 11518867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.
    Dillon JA; Rubabaza JP; Benzaken AS; Sardinha JC; Li H; Bandeira MG; dos Santos Fernando Filho E
    Sex Transm Dis; 2001 Sep; 28(9):521-6. PubMed ID: 11518869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.
    Giles JA; Falconio J; Yuenger JD; Zenilman JM; Dan M; Bash MC
    J Infect Dis; 2004 Jun; 189(11):2085-93. PubMed ID: 15143477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.